City

Bethesda (1)

Seoul (1)

Condition

Bile Duct Neoplasm (2)

Biliary Tract Malignancy (1)

Cholangiocarcinoma (1)

Obstructive Jaundice (1)

Overall Status

Recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 3 (1)

Sponsor

National Cancer Institute (NCI) (1)

Samsung Medical Center (1)

Collaborator

Intervention

parallel stent (1)

tivozanib (1)

y-stent (bonastent m-hilar) (1)

Study Documents

Intervention Type

device (1)

drug (1)

procedure (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

bile duct neoplasm

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Cholangiocarcinoma, Bile Duct Tumor, Biliary Tract Malignancy Trial run by the National Cancer Institute (NCI) (Tivozanib)

Recruiting

Cholangiocarcinoma
+2 more

Tivozanib

Bethesda, Maryland

National Institutes of Health Clinical Center

Aug 6, 2022

Bile Duct Tumor, Obstructive Jaundice Trial in Seoul (parallel stent, Y-stent (BONASTENT M-Hilar))

Withdrawn

Bile Duct Neoplasm
Obstructive Jaundice

parallel stent
Y-stent (BONASTENT M-Hilar)

Seoul, Korea, Republic of

Samsung Medical Center

Apr 24, 2016